Carnosine

Overview

Carnosine is one of the few dipeptides with a well-documented physiological role in human tissue, meaningful concentrations in skeletal muscle and brain, and declining levels with age. As a pH buffer, antioxidant, and anti-glycation agent, it sits at the intersection of sports performance research and longevity science. Unlike many research peptides, carnosine is sold legally as a dietary supplement and has been studied in multiple human trials — though many studies are small or of limited quality.

Evidence Summary

The exercise performance evidence is solid when framed correctly: direct beta-alanine supplementation (not carnosine itself) reliably raises muscle carnosine and improves performance in high-intensity activities lasting 1–4 minutes. The anti-glycation and anti-aging evidence is more preliminary — compelling mechanistically, consistent in animal models, but lacking large-scale human RCTs. Carnosine’s rapid hydrolysis in the bloodstream by serum carnosinase in humans (as opposed to rodents, which have minimal carnosinase activity) is a confounding factor in translating animal data.

Regulatory Status

Carnosine is sold as an over-the-counter dietary supplement in the US. It is not FDA-approved for any medical indication. N-acetylcarnosine eye drops are available OTC in some markets. No prescription required.

Most Common Use Cases

Oral supplementation for anti-aging, anti-glycation (particularly in diabetic patients), and cognitive support. Beta-alanine (the rate-limiting precursor) is used more commonly than carnosine itself for sports performance, as it bypasses the carnosinase hydrolysis problem. Topical N-acetylcarnosine for early cataract prevention is a niche use with limited but interesting evidence.